Category: USFDA

Pharma USFDA Vadodara

Alembic Pharma declared 14%rise in second quarter results.

November 11, 2022
Jayanti Rawat

Alembic Pharmaceuticals reported 19% drop in net profit to Rs 133 crore despite a 14% rise…

Pharma USFDA

Lupin Pharma gets tentative approval for Hepatitis B drug.

June 8, 2022
Jayanti Rawat

Global pharma major Lupin Limited today announced that it has received tentative approval from the United…

Pharma USFDA

Lupin Pharma gets tentative approval for Hepatitis B drug.

June 8, 2022
Jayanti Rawat

Global pharma major Lupin Limited today announced that it has received tentative approval from the United…

Exit mobile version